Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Rank in Stocks
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Share Price
$6.17
Market Cap
$3.52B
Change (1 day)
-0.05%
Change (1 year)
-1.86%
Country
CN
Trade Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Category
Healthcare
Operating Margin for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Operating Margin as of October 2026 TTM: 18.33%
According to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 18.33%. At the end of 2024 the company had an Operating Margin of 35.13%.
Operating Margin history for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 18.33% | -63.80% |
| 2025 | 50.63% | 44.12% |
| 2024 | 35.13% | 163.34% |
| 2023 | 13.34% | 12.29% |
| 2022 | 11.88% | -5.34% |
| 2021 | 12.55% | 5.55% |
| 2020 | 11.89% | 9.59% |
| 2019 | 10.85% | 7.53% |
| 2018 | 10.09% | 9.08% |
| 2017 | 9.25% | 32.33% |
| 2016 | 6.99% | -0.85% |
| 2015 | 7.05% | 20.93% |
| 2014 | 5.83% | -13.50% |
| 2013 | 6.74% | 24.58% |
| 2012 | 5.41% | -12.46% |
| 2011 | 6.18% | -10.82% |
| 2010 | 6.93% | -4.55% |
| 2009 | 7.26% | 83.33% |
| 2008 | 3.96% | -167.69% |
| 2007 | -5.85% | -65.20% |
| 2006 | -16.81% | -1,112.65% |
| 2005 | 1.66% | -47.30% |
| 2004 | 3.15% | -30.46% |
| 2003 | 4.53% | -18.23% |
| 2002 | 5.54% | 4.92% |
| 2001 | 5.28% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 10.52% | -99.43% |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -98.75% |
IN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.